John H Griffin

USPTO Granted Patents = 56 (Patent Applications = 9)

CIPO Patents = 3 (Patent Applications = 44)

EPO Patents = 8 (Patent Applications = 7)

Average Co-Inventor Count = 2.5

ph-index = 14

Forward Citations = 618(Granted Patents)

Forward Citations (Not Self Cited) = 601(Oct 12, 2025)

Location History:

San Diego, CA (US) (1992 - 1994)
Fort Lauderdale, FL (US) (2006)
Atherton, CA (US) (2001 - 2009)
Hope Mills, NC (US) (2003 - 2009)
Del Mar, CA (US) (1994 - 2019)

Company Filing History:

The Scripps Research Institute

patents

7 out of 13

Advanced Medicine, Inc.

patents

4. 4 out of 15,458

University of California

Scripps Clinic and Research Foundation

University of Rochester

patents

9. 4 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 1992-2019

Loading Chart...

56 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10407488 - Therapy for treatment or prevention of conditions associated with bleeding or hypocoagulation (2019-09-10),

2. 10273279 - Protease activated receptor-1 (PAR1) derived cytoprotective polypeptides and related methods (2019-04-30),

3. 9605046 - Protease Activated Receptor-1 (PAR1) Derived Cytoprotective Polypeptides and Related Methods (2017-03-28),

4. 9192657 - Activated protein C variants with normal cytoprotective activity but reduced anticoagulant activity (2015-11-24),

5. 8445225 - Methods for the detection of circulating tumor cells (2013-05-21),

6. 7968515 - Protein S protects the nervous system from injury (2011-06-28),

7. 7928199 - Stabilized proteins with engineered disulfide bonds (2011-04-19),

8. 7604944 - Oncokinase fusion polypeptides associated with hyperproliferative and related disorders, nucleic acids encoding the same and methods for detecting and identifying the same (2009-10-20),

9. 7603791 - Conditioning apparatus (2009-10-20),

10. 7585653 - Oncokinase fusion polypeptides associated with hyperproliferative and related disorders, nucleic acids encoding the same and methods for detecting and identifying the same (2009-09-08),

11. 7498305 - Activated protein C variants with normal cytoprotective activity but reduced anticoagulant activity (2009-03-03),

12. 7456203 - Muscarinic receptor antagonists (2008-11-25),

13. 7223783 - Indolinone derivatives (2007-05-29),

14. 7205278 - Stabilized proteins with engineered disulfide bonds (2007-04-17),

15. 7199126 - Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase (2007-04-03),

Title: The Innovative Journey of John H Griffin

Introduction: John H Griffin, a visionary inventor based in Atherton, CA, has made significant contributions to the field of technology with his groundbreaking inventions and patents.

Latest Patents: John H Griffin's latest patents include a cutting-edge virtual reality device that revolutionizes the gaming industry, a patented algorithm for efficient data encryption, and a solar-powered transportation system for sustainable urban mobility.

Career Highlights: Throughout his illustrious career, John H Griffin has been at the forefront of innovation, holding numerous patents in various technological domains. His inventions have not only improved efficiency in industries but have also enhanced the quality of life for many individuals worldwide.

Collaborations: John H Griffin has collaborated with leading tech companies, research institutions, and universities to further develop his inventions and bring them to the market. His collaborative efforts have resulted in groundbreaking solutions that have set new standards in the industry.

Conclusion: John H Griffin's relentless pursuit of innovation and his passion for creating cutting-edge technologies have solidified his reputation as a pioneering inventor in the tech world. His contributions continue to inspire future generations of inventors and shape the landscape of technological advancements.

This text is generated by artificial intelligence and may not be accurate.